Faculty Disclosures
|
No disclosure on file
|
| Randolph S. Marshall, MD, FAAN |
The institution of Dr. Marshall has received research support from NIH. Dr. Marshall has received publishing royalties from a publication relating to health care. |
| Karen L. Furie, MD |
The institution of Dr. Furie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/BMS. Dr. Furie has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ/JNNP. The institution of Dr. Furie has received research support from NINDS. |
| Mitchell S. Elkind, MD, MS, FAAN |
Dr. Elkind has received personal compensation for serving as an employee of American Heart Association. Dr. Elkind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Atria Academy. |
| Jan Claassen, MD, PhD |
Dr. Claassen has stock in iCE Neurosystems. The institution of Dr. Claassen has received research support from NINDS. The institution of Dr. Claassen has received research support from McDonnel Foundation. Dr. Claassen has received publishing royalties from a publication relating to health care. Dr. Claassen has received publishing royalties from a publication relating to health care. |
| Joseph L. Schindler, MD |
Dr. Schindler has received personal compensation for serving as an employee of Aeromics. Dr. Schindler has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Aeromics. Dr. Schindler has received stock or an ownership interest from Aeromics. Dr. Schindler has received publishing royalties from a publication relating to health care. |
| Lauren H. Sansing, MD |
Dr. Sansing has nothing to disclose. |
| Bradford B. Thompson, MD |
Dr. Thompson has nothing to disclose. |
| Soojin Park, MD |
Dr. Park has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical Care. The institution of Dr. Park has received research support from National Institutes of Health. |
| Emily J. Gilmore, MD |
Dr. Gilmore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for carpl.ai. Dr. Gilmore has received personal compensation in the range of $0-$499 for serving as a Consultant for AAN. Dr. Gilmore has received research support from NIH. |
| Nicholas S. Potter, MD, PhD |
Dr. Potter has nothing to disclose. |
| Kevin N. Sheth, MD, FAAN |
Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care. |
| W. T. Kimberly, MD, PhD |
Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrocyte Pharmaceuticals. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acasti Pharma. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Kimberly has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurotherapeutics. Dr. Kimberly has stock in Woolsey Pharmaceuticals. Dr. Kimberly has stock in Acasti Pharma. The institution of Dr. Kimberly has received research support from NIH. The institution of Dr. Kimberly has received research support from Hyperfine, Inc.. The institution of Dr. Kimberly has received research support from Alzheimer's Association. Dr. Kimberly has received intellectual property interests from a discovery or technology relating to health care. |
| Linda C. Wendell, MD, FAAN |
Dr. Wendell has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. An immediate family member of Dr. Wendell has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Wendell has stock in Apple. An immediate family member of Dr. Wendell has stock in Apple. |
| Eric Rosenthal, MD |
Dr. Rosenthal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma, Inc. . Dr. Rosenthal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell, Inc. . The institution of Dr. Rosenthal has received research support from Sage Therapeutics. Dr. Rosenthal has received intellectual property interests from a discovery or technology relating to health care. |
| Ifeanyi O. Iwuchukwu, MD |
Dr. Iwuchukwu has nothing to disclose. |
| Nils Petersen, MD |
The institution of Dr. Petersen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Silkroad Medical. Dr. Petersen has received research support from NIH. |
| David Y. Hwang, MD, FAAN |
The institution of Dr. Hwang has received research support from NIH. The institution of Dr. Hwang has received research support from Neurocritical Care Foundation. Dr. Hwang has received personal compensation in the range of $10,000-$49,999 for serving as a Associate Medical Director with New England Donor Services. |
| M. B. Westover, MD, PhD |
Dr. Westover has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Beacon Biosignals. Dr. Westover has stock in Beacon Biosignals. The institution of Dr. Westover has received research support from NIH. Dr. Westover has received publishing royalties from a publication relating to health care. Dr. Westover has a non-compensated relationship as a cofounder with Beacon Biosignals that is relevant to AAN interests or activities. |
| Sachin Agarwal, MD, MPH |
Dr. Agarwal has nothing to disclose. |
| Shawna M. Cutting, MD, FAAN |
The institution of Dr. Cutting has received research support from Genentech. |
| Shadi Yaghi, MD |
Dr. Yaghi has nothing to disclose. |
| Santosh B. Murthy, MD |
Dr. Murthy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CarePoint. Dr. Murthy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Murthy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Stroke and Neurological disorders. The institution of Dr. Murthy has received research support from National Institutes of Health/NINDS. |
| Sahar Zafar, MD |
Dr. Zafar has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Zafar has received research support from NIH. Dr. Zafar has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker for a lecture with Marinus. |
| David J. Roh, MD |
Dr. Roh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Portola Pharmaceuticals. |
| Shyam S. Rao, MD |
No disclosure on file
|
| Namir Khandker, MD |
No disclosure on file
|
| Michael Reznik, MD |
Dr. Reznik has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Morrison Mahoney. The institution of Dr. Reznik has received research support from NIDUS. |
| Ali Mahta, MD |
Dr. Mahta has nothing to disclose. |
| Kevin Gobeske, MD |
Dr. Gobeske has nothing to disclose. |
| Sung-Min Cho, DO |
Dr. Cho has nothing to disclose. |
| Brian Mac Grory, MB BCh BAO |
An immediate family member of Dr. Mac Grory has received personal compensation for serving as an employee of Sanofi. Dr. Mac Grory has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. The institution of Dr. Mac Grory has received research support from National Institutes of Health. The institution of Dr. Mac Grory has received research support from American Heart Association. |
| Jennifer A. Kim, MD |
Dr. Kim has nothing to disclose. |
| Guido J. Falcone, MD |
The institution of Dr. Falcone has received research support from NIH. The institution of Dr. Falcone has received research support from AHA. |
| Catherine Hassett, MD |
Dr. Hassett has nothing to disclose. |
| Louis Cannizzaro, MD |
No disclosure on file
|
| Wendy Tong |
Ms. Tong has nothing to disclose. |
| Elizabeth Matthews, MD |
Dr. Matthews has nothing to disclose. |
| Katarina B. Dakay, DO |
No disclosure on file
|
| Barbara S. Gordon-Kundu, MD |
An immediate family member of Dr. Gordon-Kundu has received personal compensation for serving as an employee of Ceretype . |
| Ibrahim Migdady, MD |
Dr. Migdady has nothing to disclose. |
| Ashutosh Kaushal, MD |
No disclosure on file
|
| Vi Tran, MD |
Dr. Tran has nothing to disclose. |
| Jill T. Shah |
No disclosure on file
|
| Matthew Anderson, DO |
Dr. Anderson has nothing to disclose. |
| Aidan Azher, MD |
Dr. Azher has nothing to disclose. |
| Billie Wiggins, MD |
Dr. Wiggins has nothing to disclose. |
| Anson Wang, MD |
Dr. Wang has nothing to disclose. |
| Giorgio Caturegli |
No disclosure on file
|
| Aaron Shoskes, DO |
Dr. Shoskes has nothing to disclose. |
| Sreeja Kodali |
Ms. Kodali has nothing to disclose. |
| Alireza Shirazian, MD |
Dr. Shirazian has nothing to disclose. |
| Sumita M. Strander |
Ms. Strander has nothing to disclose. |
| Bradley Cahn |
Mr. Cahn has nothing to disclose. |
| Alexandra Kimmel |
No disclosure on file
|
| Matthew Yuen |
Mr. Yuen has nothing to disclose. |
| Mercy H. Mazurek |
Miss Mazurek has nothing to disclose. |
| Cindy Khanh P. Nguyen |
Miss Nguyen has nothing to disclose. |
| Krithika Umesh Peshwe, MD |
Dr. Peshwe has nothing to disclose. |
| Hsin Yi Chen |
Miss Chen has nothing to disclose. |
| Charles Wira |
Charles Wira has nothing to disclose. |
| Sam Payabvash |
Sam Payabvash has nothing to disclose. |
| Gordon Sze |
Gordon Sze has nothing to disclose. |
| Charles Matouk |
Charles Matouk has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Silk Road Medical. Charles Matouk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Microvention. Charles Matouk has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Navigantis. |
| Scott Moody |
No disclosure on file
|
| Sung-Min Cho |
No disclosure on file
|
| Matthew Rosen |
Matthew Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DeepSpin. Matthew Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chipiron. Matthew Rosen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Synex Medical. Matthew Rosen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nanalysis. Matthew Rosen has stock in Hyperfine. Matthew Rosen has stock in Q Bio. Matthew Rosen has stock in Vizma Life Sciences. Matthew Rosen has stock in Intact Data Services. The institution of Matthew Rosen has received research support from Imagion. Matthew Rosen has received intellectual property interests from a discovery or technology relating to health care. |